Man Ying
Overview
Explore the profile of Man Ying including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
839
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen G, Liu Y, Svirskis D, Li H, Ying M, Lu W, et al.
Pharmaceutics
. 2024 Apr;
16(4).
PMID: 38675207
Gemcitabine is a nucleoside analog effective against a number of cancers. However, it has an oral bioavailability of less than 10%, due to its high hydrophilicity and low permeability through...
2.
Chen G, Svirskis D, Lu W, Ying M, Li H, Liu M, et al.
Carbohydr Polym
. 2021 Sep;
273:118592.
PMID: 34560993
N-trimethyl chitosan (TMC) is a multifunctional polymer that can be used in various nanoparticle forms in the pharmaceutical, nutraceutical and biomedical fields. In this study, TMC was used as a...
3.
Wierzbicki I, Campeau A, Dehaini D, Holay M, Wei X, Greene T, et al.
Cell Rep
. 2019 Dec;
29(10):2979-2989.e15.
PMID: 31801066
Group A Streptococcus (GAS) is a human-specific pathogen that evades the host immune response through the elaboration of multiple virulence factors. Although many of these factors have been studied, numerous...
4.
Lu L, Zhang M, Wang X, Zhang Y, Chai Z, Ying M, et al.
Phytother Res
. 2019 Sep;
34(1):104-117.
PMID: 31515889
The side effects of docetaxel have limited its antitumor performances in the treatment of nonsmall cell lung cancer (NSCLC). To address the problem, baicalein, a bioactive flavone that exhibits antitumor...
5.
Wang X, Wang H, Jiang K, Zhang Y, Zhan C, Ying M, et al.
J Control Release
. 2018 Dec;
293:201-214.
PMID: 30527753
Liposomes with peptides motifs have been widely applied for targeted delivery of anticancer drugs. However, few studies have questioned whether peptide modification on liposomes may induce serious toxicity associated with...
6.
Ying M, Zhuang J, Wei X, Zhang X, Zhang Y, Jiang Y, et al.
Adv Funct Mater
. 2018 Oct;
28(22).
PMID: 30319322
The recent emergence of biomimetic nanotechnology has facilitated the development of next-generation nanodelivery systems capable of enhanced biointerfacing. In particular, the direct use of natural cell membranes can enable multivalent...
7.
Zhuang J, Ying M, Spiekermann K, Holay M, Zhang Y, Chen F, et al.
Adv Mater
. 2018 Oct;
30(49):e1804693.
PMID: 30294884
Blood transfusion is oftentimes required for patients suffering from acute trauma or undergoing surgical procedures in order to help maintain the body's oxygen levels. The continued demand worldwide for blood...
8.
Ying M, Wang S, Zhang M, Wang R, Zhu H, Ruan H, et al.
ACS Appl Mater Interfaces
. 2018 May;
10(23):19473-19482.
PMID: 29790744
The clinical treatment of aggressive glioma has been a great challenge, mainly because of the complexity of the glioma microenvironment and the existence of the blood-brain tumor barrier (BBTB)/blood-brain barrier...
9.
Zhang M, Lu L, Ying M, Ruan H, Wang X, Wang H, et al.
Mol Pharm
. 2018 May;
15(6):2437-2447.
PMID: 29734808
The robust proliferation of tumors relies on a rich neovasculature for nutrient supplies. Therefore, a basic strategy of tumor targeting therapy should include not only killing regular cancer cells but...
10.
Ruan H, Chai Z, Shen Q, Chen X, Su B, Xie C, et al.
J Control Release
. 2018 Apr;
279:306-315.
PMID: 29679668
The receptor associated protein (RAP) is a 39 kDa chaperone protein, binding tightly to low-density lipoprotein receptor-related protein-1 (LRP1) that is overexpressed in glioma, tumor neovasculature, vasculogenic mimicry (VM), the...